[Bacteria of the Acinetobacter genus]. 1998

M L Joly-Guillou
Service de Microbiologie (Dr Boussougant), Hôpital Louis Mourier, Colombes, France.

Bacteria of the Acinetobacter genus received little attention for many years because of their weak pathogenic potential and changing taxonomy. Since the introduction starting in the 1980s of an ever increasing number of antimicrobials, these organisms have demonstrated their ability to adapt. They are causing an increasing number of nosocomial infections, most notably in intensive care units. The selection pressure exerted by antimicrobials and the use of increasingly invasive diagnostic and therapeutic procedures are the main factors that promote emergence of Acinetobacter in high-risk patients. Acinetobacter exhibit a high level of resistance to antimicrobials and are capable of persisting in hostile environments (humidity or dryness, presence of some antiseptics). As a result, they can cause nosocomial outbreaks. Identification of carriers and colonized patients, rigorous isolation, and scrupulous cleaning procedures are effective control measures. Despite these efforts, however, Acinetobacter baumannii now contributes a significant proportion of nosocomial infections.

UI MeSH Term Description Entries
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000150 Acinetobacter A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity. Herellea,Mima
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

M L Joly-Guillou
January 1983, Laboratornoe delo,
M L Joly-Guillou
January 1993, Medycyna doswiadczalna i mikrobiologia,
M L Joly-Guillou
January 1992, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M L Joly-Guillou
January 1993, Medycyna doswiadczalna i mikrobiologia,
M L Joly-Guillou
January 1982, Mikrobiologicheskii zhurnal,
M L Joly-Guillou
June 1986, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M L Joly-Guillou
January 1980, Memorias do Instituto Oswaldo Cruz,
M L Joly-Guillou
January 2006, Pneumonologia i alergologia polska,
M L Joly-Guillou
January 1991, Medycyna doswiadczalna i mikrobiologia,
M L Joly-Guillou
May 1986, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Copied contents to your clipboard!